Conformis Announces 510(k) Clearance for Cordera™ Hip System

NEXT STORY
GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
PREV STORY
Dr. Stephen Sinatra’s Omega Q Plus ULTRA by Healthy Directions Targets Emotional Stress Affecting Heart Health
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cidara Provides Corporate Update and Reports Second Quarter 2018 Financial Results

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a ...

author_avatar
NASDAQ Market News

Vical Initiates Phase 1 Trial of Novel Antifungal Compound VL-2397

SAN DIEGO, March 07, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the ...

author_avatar
NASDAQ Market News

Radius Health Presents Positive Data for TYMLOS™ (abaloparatide) Injection from the ACTIVExtend Trial at ASBMR 2017 Annual Meeting

ACTIVExtend trial demonstrated statistically significant fracture risk reduction through the 3.5 years of sequential ...

author_avatar
NASDAQ Market News